Login / Signup

Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy.

Hye Na JungSung Mok KimJeong Hyun LeeYiseul KimSang-Chol LeeEun-Seok JeonHwan Seok YongYeon Hyeon Choe
Published in: Acta radiologica (Stockholm, Sweden : 1987) (2019)
SRABR and SRABC were reliable parameters for distinguishing between CA and HCM.
Keyphrases
  • hypertrophic cardiomyopathy
  • left ventricular
  • magnetic resonance
  • heart failure
  • multiple myeloma
  • contrast enhanced
  • protein kinase
  • clinical evaluation